Retour
Fourchette du Jour
9,96 €
10,37 €
Fourchette 52 Semaines
5,90 €
14,51 €
Volume
683 589
Moyenne 50J / 200J
12,71 €
/
10,01 €
Clôture Précédente
10,32 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -8,2 | 0,3 |
| P/B | 1,5 | 2,9 |
| ROE % | -16,2 | 3,7 |
| Net Margin % | -30,8 | 3,8 |
| Rev Growth 5Y % | 48,8 | 10,0 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Hold
12,50 €
+21.5%
Low: 6,00 €
High: 18,00 €
BPA Prévisionnel
-3,32 €
CA Est.
93 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
-0,63 €
-1,30 € – -0,17 €
|
280 M | 6 |
| FY2029 |
-1,87 €
-3,84 € – -0,49 €
|
210 M | 6 |
| FY2028 |
-2,14 €
-3,75 € – 2,83 €
|
160 M | 8 |
Points Clés
Revenue grew 48,78% annually over 5 years — strong growth
Debt/Equity of 0,02 — conservative balance sheet
Negative free cash flow of -275,70M
PEG of 0,18 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 49,08%
Capital efficient — spends only 0,72% of revenue on capex
Croissance
Revenue Growth (5Y)
48,78%
Revenue (1Y)-0,30%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-16,23%
ROIC-19,48%
Net Margin-30,77%
Op. Margin-43,75%
Sécurité
Debt / Equity
0,02
Current Ratio4,92
Interest Coverage0,00
Valorisation
P/E Ratio
-8,18
P/B Ratio1,52
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -0,30% | Revenue Growth (3Y) | 82,90% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 48,78% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 262,60M | Net Income (TTM) | -80,80M |
| ROE | -16,23% | ROA | -11,26% |
| Gross Margin | 98,02% | Operating Margin | -43,75% |
| Net Margin | -30,77% | Free Cash Flow (TTM) | -275,70M |
| ROIC | -19,48% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,02 | Current Ratio | 4,92 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -8,18 | P/B Ratio | 1,52 |
| P/S Ratio | 2,52 | PEG Ratio | 0,18 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 660,87M | Enterprise Value | 526,47M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 262,60M | 263,40M | 78,50M | 131,40M | 53,60M |
| Net Income | -80,80M | -198,90M | -367,30M | -282,50M | -191,00M |
| EPS (Diluted) | -1,28 | -2,77 | -6,62 | -5,31 | -3,82 |
| Gross Profit | 257,40M | 263,40M | 78,50M | 131,40M | 53,60M |
| Operating Income | -114,90M | -250,20M | -401,50M | -263,20M | -188,40M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 717,90M | 1,09B | 1,30B | 1,27B | 1,58B |
| Total Liabilities | 284,00M | 529,70M | 644,60M | 703,90M | 799,90M |
| Shareholders' Equity | 433,90M | 561,70M | 660,00M | 564,90M | 781,70M |
| Total Debt | 8,50M | 9,70M | 3,20M | 5,50M | 5,00M |
| Cash & Equivalents | 142,90M | 100,50M | 311,70M | 81,30M | 108,30M |
| Current Assets | 700,70M | 1,07B | 1,28B | 1,24B | 1,55B |
| Current Liabilities | 142,50M | 229,80M | 257,10M | 295,10M | 261,70M |